Cargando…
Development and validation of a pharmacy migraine questionnaire to assess suitability for treatment with a triptan
A questionnaire (Migraine Questionnaire; MQ) was developed to help pharmacists identify consumers with migraine suitable for non-prescription treatment with a triptan. Adults, who knew or thought that they had migraine, participated in three, sequential, community-based studies to validate the MQ. O...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Milan
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3452080/ https://www.ncbi.nlm.nih.gov/pubmed/18953489 http://dx.doi.org/10.1007/s10194-008-0070-6 |
_version_ | 1782244430940471296 |
---|---|
author | Diener, Hans-Christoph Dowson, Andrew Whicker, Susan Bacon, Teresa |
author_facet | Diener, Hans-Christoph Dowson, Andrew Whicker, Susan Bacon, Teresa |
author_sort | Diener, Hans-Christoph |
collection | PubMed |
description | A questionnaire (Migraine Questionnaire; MQ) was developed to help pharmacists identify consumers with migraine suitable for non-prescription treatment with a triptan. Adults, who knew or thought that they had migraine, participated in three, sequential, community-based studies to validate the MQ. Overall, 1,353 subjects completed independent assessments with a pharmacist and a clinician (reference standard). The accuracy of the pharmacist assessment of suitability for a triptan was compared with the clinician assessment. Clinicians using their standard practice determined that triptan therapy was suitable in 76.8% of cases compared with 48.8% for pharmacists using the MQ. The lack of concordance between pharmacists and clinicians in the false-positive cases (n = 113 of 660 subjects considered suitable for triptan by the pharmacists) usually related to headache diagnosis (57.5%), not safety aspects. The MQ is an effective tool for pharmacists to guide appropriate recommendation of a non-prescription triptan for migraine. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s10194-008-0070-6) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-3452080 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2008 |
publisher | Springer Milan |
record_format | MEDLINE/PubMed |
spelling | pubmed-34520802012-11-29 Development and validation of a pharmacy migraine questionnaire to assess suitability for treatment with a triptan Diener, Hans-Christoph Dowson, Andrew Whicker, Susan Bacon, Teresa J Headache Pain Original A questionnaire (Migraine Questionnaire; MQ) was developed to help pharmacists identify consumers with migraine suitable for non-prescription treatment with a triptan. Adults, who knew or thought that they had migraine, participated in three, sequential, community-based studies to validate the MQ. Overall, 1,353 subjects completed independent assessments with a pharmacist and a clinician (reference standard). The accuracy of the pharmacist assessment of suitability for a triptan was compared with the clinician assessment. Clinicians using their standard practice determined that triptan therapy was suitable in 76.8% of cases compared with 48.8% for pharmacists using the MQ. The lack of concordance between pharmacists and clinicians in the false-positive cases (n = 113 of 660 subjects considered suitable for triptan by the pharmacists) usually related to headache diagnosis (57.5%), not safety aspects. The MQ is an effective tool for pharmacists to guide appropriate recommendation of a non-prescription triptan for migraine. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s10194-008-0070-6) contains supplementary material, which is available to authorized users. Springer Milan 2008-10-25 /pmc/articles/PMC3452080/ /pubmed/18953489 http://dx.doi.org/10.1007/s10194-008-0070-6 Text en © The Author(s) 2008 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
spellingShingle | Original Diener, Hans-Christoph Dowson, Andrew Whicker, Susan Bacon, Teresa Development and validation of a pharmacy migraine questionnaire to assess suitability for treatment with a triptan |
title | Development and validation of a pharmacy migraine questionnaire to assess suitability for treatment with a triptan |
title_full | Development and validation of a pharmacy migraine questionnaire to assess suitability for treatment with a triptan |
title_fullStr | Development and validation of a pharmacy migraine questionnaire to assess suitability for treatment with a triptan |
title_full_unstemmed | Development and validation of a pharmacy migraine questionnaire to assess suitability for treatment with a triptan |
title_short | Development and validation of a pharmacy migraine questionnaire to assess suitability for treatment with a triptan |
title_sort | development and validation of a pharmacy migraine questionnaire to assess suitability for treatment with a triptan |
topic | Original |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3452080/ https://www.ncbi.nlm.nih.gov/pubmed/18953489 http://dx.doi.org/10.1007/s10194-008-0070-6 |
work_keys_str_mv | AT dienerhanschristoph developmentandvalidationofapharmacymigrainequestionnairetoassesssuitabilityfortreatmentwithatriptan AT dowsonandrew developmentandvalidationofapharmacymigrainequestionnairetoassesssuitabilityfortreatmentwithatriptan AT whickersusan developmentandvalidationofapharmacymigrainequestionnairetoassesssuitabilityfortreatmentwithatriptan AT baconteresa developmentandvalidationofapharmacymigrainequestionnairetoassesssuitabilityfortreatmentwithatriptan |